The approved qualified claims included:
- One study suggest that consuming tomatoes does not reduce the risk of pancreatic cancer, but one weaker, more limited study suggest that consuming tomatoes may reduce this risk. Based on these studies, FDA concludes that it is highly unlikely that tomatoes reduce the risk of pancreatic cancer.
- One study suggest that consumption of tomatoe sauce two times a week may reduce the risk of ovarian cancer.; while this same study shows that consumption of tomatoes or tomatoe juice had no effect on ovarian cancer risk. FDA concludes that it is highly unlikey that tomatoes reduces the risk of ovarian cancer.
- Very limited and preliminary scientific reasearch suggest that eating one-half to one cup of tomatoes and/or tomatoe sauce a week may reduce the risk of prostate cancer. FDA concludes that there is little scientific eveidence supporting the claim.
- Four studies did not show that tomatoe intake reduces the risk of gastric cancer, but three studies suggest that tomatoe intake may reduce this risk. Based on these studies, FDA concludes that it is unlikey that tomatoes reducethe risk of gastric cancer.
